Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology.
about
Helicobacter pyloriEfficacy of Helicobacter pylori eradication therapies: a single centre observational studyEvaluation and management of dyspepsia.Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate.Absence of abdominal pain in older persons with endoscopic ulcers: a prospective study.Interventions designed to improve the quality and efficiency of medication use in managed care: a critical review of the literature - 2001-2007Socio-demographic characteristics of patients with diagnosed functional dyspepsia.Exploring novel vaccines against Helicobacter pylori: protective and therapeutic immunization.Helicobacter pylori eradication in dyspeptic primary care patients: a randomized controlled trial of a pharmacy intervention.Dyspepsia, peptic ulcer disease, and esophageal reflux diseaseIs Helicobacter pylori associated with non-ulcer dyspepsia and will eradication improve symptoms? A meta-analysis.Regular review: treatment of Helicobacter pylori infection.The quality of care for Medicare patients with peptic ulcer disease.Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus: chronic infections and coronary heart disease.Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database.Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer.Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding.What is heartburn worth? A cost-utility analysis of management strategiesGastroprotective and anti-Helicobacter pylori potential of herbal formula HZJW: safety and efficacy assessment.The cost-effectiveness of competing strategies for the prevention of recurrent peptic ulcer hemorrhage.14C-urea breath test in patients undergoing anti-tuberculosis therapyIn vitro synergy testing of clarithromycin and 14-hydroxyclarithromycin with amoxicillin or bismuth subsalicylate against Helicobacter pyloriPrevalence of anti-ulcer drug use in a Chinese cohortEvidence for the role of gastric mucosa at the secretion of soluble triggering receptor expressed on myeloid cells (strem-1) in peptic ulcer disease.Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in TurkeyDifferential diagnosis between functional and organic intestinal disorders: is there a role for non-invasive tests?Is Helicobacter pylori being treated appropriately? A study of inpatients and outpatients in a tertiary care centre.Gastric biopsies: the gap between evidence-based medicine and daily practice in the management of gastric Helicobacter pylori infection.Mechanisms of action of systemic antibiotics used in periodontal treatment and mechanisms of bacterial resistance to these drugs.Review: eradication of Helicobacter pylori. Problems and recommendations.A pilot study to determine the effectiveness of garlic oil capsules in the treatment of dyspeptic patients with Helicobacter pylori.Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection.Effect of Helicobacter pylori infection and its eradication on nutrition.Who is using chronic acid suppression therapy and why?Pharmacogenomics-based tailored versus standard therapeutic regimen for eradication of H. pylori.Controlled trial of interventions to increase testing and treatment for Helicobacter pylori and reduce medication use in patients with chronic acid-related symptoms.DNA typing for Helicobacter pylori isolates from eradication-failed patients: comparison of the isolates before and after therapy.Comparison of two management strategies for Helicobacter pylori treatment: clinical study and cost-effectiveness analysis.Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.Modified allele-specific primer-polymerase chain reaction method for analysis of susceptibility of Helicobacter pylori strains to clarithromycin.
P2860
Q24683623-A6986D3F-E824-484C-A8A6-6D535A56E0D1Q24803928-FEDBDF7A-1691-4D91-AEAD-3BA844523C36Q30433839-8E6B1AB0-6FDC-4843-B8FE-31A5E73149ECQ32026744-B91BDDE9-3C77-4619-8E5F-3FDEC1B16DB7Q32090449-6E13124B-4288-4066-A67E-23F35126573CQ33327179-71981C3B-01B1-4543-9E6D-D4A7AD1E4B5BQ33636671-4B192072-28B1-4579-8122-4134C180EC5AQ33727845-10632D25-DB70-4B44-AE47-849214ACD704Q33729625-42329D0E-07BE-49D0-B7FD-548406B24C2DQ33729631-BBDDA3AC-08AB-4941-842A-10E1B30CA69CQ33751783-8781624B-439C-4E8F-9E99-780DFE84EF93Q33807123-5996C759-1D0C-4ACC-A0DA-15A1F1600CF6Q33819469-D8AFAF8A-52FA-40DD-B8A3-2A0572E7AB85Q33821315-7DF8A508-DA98-4AFC-93CE-DEF91D37FF0FQ33827140-4E42E8D1-F5FE-483E-8AD0-4EF35507E5ADQ34546364-252F691C-1FCC-48F4-BB5C-7147E37D3BC8Q34581560-6513D926-1403-4C6E-B5C6-674998E2624AQ34745082-44FA7440-611C-42A9-9AE9-946E29628A1DQ34747906-A6B9C488-2168-46A8-AF05-C68A88AAD9A6Q34791842-3C5945AF-0FC4-455E-961E-0546B018E1B7Q35011442-F54519A9-160C-4E3B-8BE8-1C79E6523B6FQ35137399-9E2B56EA-9A2C-45EE-86DC-59B9FF871CE3Q36179882-9D11517F-8991-4C55-A357-D90A1E53DA21Q36179953-C3849455-E86B-4C7E-897A-FFD65D825F36Q36474120-E7EDDF3E-D473-4348-89DF-9BD0964EA056Q36709455-132A2551-37BD-4656-936E-DDE7C06AA8BFQ37133479-86D04B4E-7481-40CE-BA63-41BE0230A449Q37247773-F6E947F9-9E70-4B76-968E-F9EC31405E63Q37437540-2AC7DB03-6AE4-4FAA-8CDF-74F2DDE40074Q39453816-3D58CE0C-3F79-4DB0-B0FF-74079068C4CBQ40679020-7E2CF0BD-7ECE-47E8-B5F8-D41EF6BCF1AEQ42546090-F6D7A7F6-0E62-44C4-BF63-900A7EC23596Q43670782-8E4532DD-95E5-4669-99EC-347B6FC81BEBQ44277473-80A01A19-FB06-4441-907D-16B8F2ED9A33Q44371256-596E1060-5F99-483C-A0E9-8CB3F65B219FQ44642449-F622B6BB-4140-4250-B583-B12EF81D12F6Q45009867-11B132F7-0A75-4304-981B-62E5FAD50A6CQ45250901-A9E0A09A-1879-4765-9B5E-843A02922B9EQ46534922-5487A307-A4AE-44AE-9C92-BDB1E288811BQ46967724-2E197245-B078-4CEE-8FCF-84F25699463B
P2860
Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Consensus conference. Medical ...... n College of Gastroenterology.
@en
type
label
Consensus conference. Medical ...... n College of Gastroenterology.
@en
prefLabel
Consensus conference. Medical ...... n College of Gastroenterology.
@en
P356
P1476
Consensus conference. Medical ...... n College of Gastroenterology.
@en
P2093
P304
P356
10.1001/JAMA.275.8.622
P407
P577
1996-02-01T00:00:00Z